1. The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases
- Author
-
Jerónimo Aragón-Vela, Julio Plaza-Díaz, Alejandro Egea-Zorrilla, Francisco Abadía-Molina, Sergio Muñoz-Quezada, Luis Tercedor-Sánchez, and Estefania Sanchez-Rodriguez
- Subjects
0301 basic medicine ,Heart disease ,microbiome ,lcsh:TX341-641 ,Review ,Gut microbiota ,Disease ,030204 cardiovascular system & hematology ,Gut flora ,Bioinformatics ,digestive system ,law.invention ,Pathogenesis ,03 medical and health sciences ,Probiotic ,0302 clinical medicine ,law ,medicine ,Animals ,Humans ,Molecular Targeted Therapy ,Microbiome ,Precision Medicine ,Stroke ,Nutrition and Dietetics ,gut microbiota ,biology ,business.industry ,Probiotics ,Fecal Microbiota Transplantation ,Atherosclerosis ,biology.organism_classification ,medicine.disease ,cardiovascular diseases ,Gastrointestinal Microbiome ,Cardiovascular diseases ,030104 developmental biology ,Blood pressure ,atherosclerosis ,business ,lcsh:Nutrition. Foods and food supply ,Food Science - Abstract
Julio Plaza-Díaz is part of the “UGR Plan Propio de Investigación 2016” and the “Excellence actions: Unit of Excellence on Exercise and Health (UCEES), University of Granada”. We are grateful to Belen Vazquez-Gonzalez for assistance with the illustration service., The importance of gut microbiota in health and disease is being highlighted by numerous research groups worldwide. Atherosclerosis, the leading cause of heart disease and stroke, is responsible for about 50% of all cardiovascular deaths. Recently, gut dysbiosis has been identified as a remarkable factor to be considered in the pathogenesis of cardiovascular diseases (CVDs). In this review, we briefly discuss how external factors such as dietary and physical activity habits influence host-microbiota and atherogenesis, the potential mechanisms of the influence of gut microbiota in host blood pressure and the alterations in the prevalence of those bacterial genera affecting vascular tone and the development of hypertension. We will also be examining the microbiota as a therapeutic target in the prevention of CVDs and the beneficial mechanisms of probiotic administration related to cardiovascular risks. All these new insights might lead to novel analysis and CVD therapeutics based on the microbiota.
- Published
- 2020
- Full Text
- View/download PDF